SCARA5 inhibits oral squamous cell carcinoma via inactivating the STAT3 and PI3K/AKT signaling pathways.

Huang J, Lv C, Zhao B, Ji Z, Gao Z

Open source

DOI
10.1515/med-2023-0627
Published
2023
Container
Open medicine (Warsaw, Poland)
Publisher
Not recorded
Open access
yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1515/med-2023-0627,
  title = {SCARA5 inhibits oral squamous cell carcinoma via inactivating the STAT3 and PI3K/AKT signaling pathways.},
  author = {Huang J and Lv C and Zhao B and Ji Z and Gao Z},
  year = {2023},
  journal = {Open medicine (Warsaw, Poland)},
  doi = {10.1515/med-2023-0627},
  url = {https://doi.org/10.1515/med-2023-0627}
}

RIS

TY  - JOUR
TI  - SCARA5 inhibits oral squamous cell carcinoma via inactivating the STAT3 and PI3K/AKT signaling pathways.
AU  - Huang J
AU  - Lv C
AU  - Zhao B
AU  - Ji Z
AU  - Gao Z
PY  - 2023
JO  - Open medicine (Warsaw, Poland)
DO  - 10.1515/med-2023-0627
UR  - https://doi.org/10.1515/med-2023-0627
ER  - 

APA

J, H., C, L., B, Z., Z, J., & Z, G. (2023). SCARA5 inhibits oral squamous cell carcinoma via inactivating the STAT3 and PI3K/AKT signaling pathways.. Open medicine (Warsaw, Poland). https://doi.org/10.1515/med-2023-0627

Source records